Omron, InterCure jointly address UK hypertension market:
This article was originally published in Clinica
Omron Healthcare, a UK-based subsidiary of Japanese sensing technology specialist, is teaming up with InterCure, the New York, US-based developer of the RESPeRATE device for lowering blood pressure, in a co-marketing effort aimed at the UK hypertension market. As part of the agreement, Omron will include product information about RESPeRATE in boxes of its M10i blood pressure monitors, while InterCure will provide information on Omron's product in its RESPeRATE packaging.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.